gonadorelin
Gonadorelin, explained.
Gonadorelin is synthetic GnRH — the signal the hypothalamus uses at the top of the reproductive axis. This page is a neutral, educational overview of what it is, how it works, and how it is classified. It is not medical advice and does not recommend use.
Educational only — not medical advice. Consult a qualified licensed provider.
Gonadorelin is synthetic gonadotropin-releasing hormone (GnRH, also called LHRH) — a 10-amino-acid peptide identical to the hormone the hypothalamus secretes. It acts on the pituitary to release LH and FSH, which in turn relate to testosterone, sperm, and ovulation. It is a prescription drug with a long approved history, though no branded product is currently marketed in the US.
What gonadorelin is
Gonadorelin is synthetic GnRH — gonadotropin-releasing hormone, sometimes called LHRH — a small decapeptide (ten amino acids) that is chemically identical to the hormone the hypothalamus makes to regulate reproduction. It sits at the top of the hypothalamic-pituitary-gonadal (HPG) axis. Historically it was marketed as branded products: Factrel, in the context of diagnostic GnRH-stimulation testing, and Lutrepulse, a pulsatile pump formulation investigated in fertility research. It has also been studied in the research context of testosterone therapy. It is a prescription drug with a long clinical track record — but no branded FDA-approved gonadorelin product is currently marketed in the United States, so most present-day supply comes from compounding pharmacies or research-grade sources, and any testosterone-therapy context is off-label.
How gonadorelin works
Gonadorelin binds GnRH receptors on the pituitary gland, which can prompt release of two gonadotropins: LH (luteinizing hormone) and FSH (follicle-stimulating hormone). Those two hormones do the downstream work — LH relates to testosterone production in the testes and steroid production in the ovaries, while FSH relates to sperm production and follicle development. A key detail is timing. The axis responds to pulses: intermittent, on-and-off stimulation that mimics the body's natural rhythm can drive the system, whereas continuous, sustained exposure paradoxically suppresses it. That dual behavior is well established — it is why pulsatile delivery was studied for fertility, and also why related long-acting GnRH agonists are used elsewhere to suppress the axis on purpose. Because gonadorelin's half-life is only about two to four minutes, a single injection produces just a brief LH/FSH pulse, and it acts only if the pituitary and gonads are intact and able to respond.
Areas of research interest
- Testicular function during testosterone therapy — an off-label research context examined in relation to the historical role of hCG
- The HPG axis and LH/FSH signaling in the setting of exogenous testosterone — a subject of research interest
- Pulsatile fertility therapy for hypothalamic amenorrhea — the historical approved Lutrepulse context
- Diagnostic GnRH-stimulation testing — measuring the LH/FSH response to assess pituitary and gonadal function
- The HPG axis as a model — how an upstream pituitary signal differs from acting directly at the gonad
Safety & legal status
In the literature, gonadorelin is generally described as well tolerated, with injection-site reactions, headache, nausea, flushing, and abdominal discomfort reported; rare hypersensitivity and anaphylaxis have occurred, and pulsatile fertility use carries a multiple-gestation risk. None of this is medical advice — consult a qualified licensed provider about your own situation. Legally, gonadorelin is a prescription drug with a long approved history (Factrel, Lutrepulse), but no branded FDA-approved product is currently marketed in the US, so supply is largely compounded or research-grade, where identity and purity vary. Availability and legal status differ by country.
Gonadorelin vs hCG vs kisspeptin
| Gonadorelin | hCG | Kisspeptin | |
|---|---|---|---|
| What it is | Synthetic GnRH (the body's own signal) | Hormone that mimics LH | Peptide that triggers GnRH release |
| Where it acts | On the pituitary (upstream) | At the gonad (downstream) | On GnRH neurons (furthest upstream) |
| What it releases | The body's own LH and FSH | Acts in place of LH directly | Stimulates natural GnRH, then LH/FSH |
| Common context | TRT adjunct, fertility, diagnostics | TRT adjunct, fertility | Research / upstream axis modulation |
| Approval status | Prescription; no branded US product now | FDA-approved prescription | Investigational / research-stage |
Frequently asked
What are gonadorelin's side effects?+
It is generally described as well tolerated. Reported effects include injection-site reactions, headache, nausea, flushing, and abdominal discomfort. Rare hypersensitivity and anaphylaxis have been reported, and pulsatile fertility use carries a multiple-gestation risk. It acts only if the pituitary and gonads can respond.
Why is gonadorelin studied alongside testosterone therapy?+
Exogenous testosterone suppresses the body's own LH, which is associated with reduced testicular size and fertility. Pulsed gonadorelin has been investigated in research on whether the pituitary releases LH and FSH in this setting — an off-label context studied alongside hCG. Evidence is limited and this is educational information, not medical advice.
Is gonadorelin a steroid?+
No. Gonadorelin is a peptide identical to natural GnRH. It is not an anabolic steroid and does not work like one — it signals the pituitary to release the body's own LH and FSH, which then relate to hormones like testosterone indirectly.
Is gonadorelin FDA approved?+
It was approved historically as Factrel (diagnostic testing) and Lutrepulse (pulsatile fertility therapy), but no branded FDA-approved gonadorelin product is currently marketed in the US as of 2026. Current supply is largely compounded or research-grade, and TRT-adjunct use is off-label.
Everything peptides, made easy.
Join PepEasy and get the tools, the knowledge, and the care — in one place.
Explore more